MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
MRC Nutrition and Bone Health Research Group, Cambridge, UK.
Nat Rev Endocrinol. 2019 Sep;15(9):535-547. doi: 10.1038/s41574-019-0220-8.
Osteoporosis is associated with increased fragility of bone and a subsequent increased risk of fracture. The diagnosis of osteoporosis is intimately linked with the imaging and quantification of bone and BMD. Scanning modalities, such as dual-energy X-ray absorptiometry or quantitative CT, have been developed and honed over the past half century to provide measures of BMD and bone microarchitecture for the purposes of clinical practice and research. Combined with fracture prediction tools such as Fracture Risk Assessment Tool (FRAX) (which use a combination of clinical risk factors for fracture to provide a measure of risk), these elements have led to a paradigm shift in the ability to diagnose osteoporosis and predict individuals who are at risk of fragility fracture. Despite these developments, a treatment gap exists between individuals who are at risk of osteoporotic fracture and those who are receiving therapy. In this Review, we summarize the epidemiology of osteoporosis, the history of scanning modalities, fracture prediction tools and future directions, including the most recent developments in prediction of fractures.
骨质疏松症与骨脆性增加和随后骨折风险增加有关。骨质疏松症的诊断与骨和骨密度的成像和定量密切相关。在过去的半个世纪中,已经开发和完善了扫描方式,如双能 X 射线吸收法或定量 CT,以提供用于临床实践和研究的骨密度和骨微观结构的测量。这些元素与骨折预测工具(如骨折风险评估工具(FRAX))相结合(该工具使用骨折的临床危险因素组合来提供风险衡量标准),导致了诊断骨质疏松症和预测脆性骨折风险个体的能力发生了范式转变。尽管有这些发展,但在有发生骨质疏松性骨折风险的个体和接受治疗的个体之间存在治疗差距。在这篇综述中,我们总结了骨质疏松症的流行病学、扫描方式的历史、骨折预测工具和未来的发展方向,包括骨折预测的最新进展。